Fish oil, lean tissue, and cancer: Is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome?

Critical Reviews in Oncology/Hematology

Volumn 55, Issue 1, 2005, Pages 37-43

  Jatoi, Aminah ^a,b  

^a MAYO CLINIC   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cachexia; Cancer; Eicosapentaenoic acid; Fish oil; Omega 3 fatty acids; Weight loss

Indexed keywords

CORTICOSTEROID; FISH OIL; GESTAGEN; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE;

ANOREXIA; APPETITE DISORDER; BODY COMPOSITION; CANCER; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; NUTRITION; QUALITY OF LIFE; REVIEW; WEIGHT REDUCTION; WELLBEING;

ANOREXIA; CLINICAL TRIALS; EICOSAPENTAENOIC ACID; FISH OILS; HUMANS; NEOPLASMS; SYNDROME; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 20344373897     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.01.004     Document Type: Review

References (25)

1. D. Walsh, S. Donnelly, and L. Rybicki The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients Supportive Care Cancer 8 2000 175 179
2. N. Sarhill, F. Mahmoud, and D. Walsh Evaluation of nutritional status in advanced metastatic cancer Supportive Care Cancer 11 2003 652 659
3. R. Roubenoff, and J.J. Kehayias The meaning and measurement of lean body mass Nutr Rev 49 1991 163 175
4. D.M. Finkelstein, B.R. Cassileth, and P.D. Bonomi A pilot study of the Functional Living Index scale for the assessment of quality of life for metastatic lung cancer patients: an Eastern Cooperative Oncology Group study Am J Clin Oncol 11 1988 630 633
5. W.D. Dewys, C. Begg, and P.T. Lavin Prognostic effect of weight loss prior to chemotherapy in cancer patients Am J Med 69 1980 491 497
6. C.L. Loprinzi, K.A. Laurie, and H.S. Wiend Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group J Clin Oncol 12 1994 601 607
7. M. Tamburini, C. Brunelli, S. Rosso, and V. Ventafridda Prognostic value of quality of life scores in terminal cancer patients J Pain Symptom Manage 11 1996 32 41
8. A. Jatoi, and C.L. Loprinzi Current management of cancer-associated anorexia and weight loss Oncology 15 2001 497 502
9. Y. Zhao, S. Joshi-Barve, S. Barve, and L.H. Chen Eicosapentaenoic acid prevents LPS-induced TNF alpha expression by preventing NF kappa B activation J Am Coll Nutr 23 2004 71 78
10. C.L. Loprinzi, N.M. Ellison, and D.J. Schaid Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia 82 1990 1127 1132
11. A. Jatoi, S. Kumar, J.A. Sloan, and P.L. Nguyen On appetite and its loss J Clin Oncol 18 2000 2930 2932
12. I.H. Rosenberg Fish - food to calm the heart N Engl J Med 346 2002 1102 1103
13. S.J. Wigmore, K.C.H. Fearon, and J.P. Maingay Down regulation of the acute phase response in patients with pancreatic cancer cachexia receiving eicosapentaenoic acid is mediated via suppression of interleukin-6 Clin Sci 92 1997 215 221
14. V.E. Baracos, C. DeVivo, and D.H. Hoyle Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma Am J Physiol 268 5 Pt 1 1995 E996 E1006
15. D.D. Lazarus, A.T. Destree, and L.M. Mazzola A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway Am J Physiol 277 1999 E332 E341
16. M. Bossola, M. Muscaritoli, and P. Costelli Increased muscle proteasome activity correlates with disease severity in gastric cancer patients Ann Surg 237 2003 384 389
17. A.S. Whitehouse, H.J. Smith, and J.L. Drake Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid Cancer Res 61 2001 3604 3609
18. P. Todorov, P. Cariuk, and T. McDEvitt Characterization of a cancer cachectic factor Nature 379 1996 739 742
19. H.J. Smith, M.J. Lorite, and M.J. Tisdale Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: modulation by eicosapentaenoic acid Cancer Res 59 1999 5507 5513
20. C.P. Burns, S. Halabi, and G.H. Clamon Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and Leukemia Group B Study 9473 Clin Cancer Res 5 1999 3942 3947
21. C.A. Gogos, P. Ginopoulos, and B. Salsa Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immune deficiency and prolong survival for severely ill patients with generalized malignancy Cancer 82 1998 395 402
22. M.D. Barber, J.A. Ross, and A.C. Voss The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer Br J Cancer 81 1999 80 86
23. E. Bruera, F. Strasser, and J.L. Palmer Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double blind, placebo controlled study J Clin Oncol 21 2003 129 134
24. K.C. Fearon, M.F. Von Meyenfeldt, and A.G. Moses Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial Gut 52 2001 1479 1486
25. A. Jatoi, K. Rowland, and C.L. Loprinzi An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort J Clin Oncol 22 2004 2469 2476